Regent Peak Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,938
| Closed | -$201K | – | 192 |
|
|
2024
Q3 | $201K | Sell |
6,938
-3,772
| -35% | -$109K | 0.05% | 172 |
|
|
2024
Q2 | $300K | Sell |
10,710
-49
| -0.5% | -$1.37K | 0.07% | 121 |
|
|
2024
Q1 | $299K | Sell |
10,759
-2,807
| -21% | -$77.9K | 0.08% | 121 |
|
|
2023
Q4 | $391K | Sell |
13,566
-199
| -1% | -$5.73K | 0.11% | 95 |
|
|
2023
Q3 | $457K | Sell |
13,765
-603
| -4% | -$20K | 0.14% | 82 |
|
|
2023
Q2 | $527K | Sell |
14,368
-336
| -2% | -$12.3K | 0.15% | 77 |
|
|
2023
Q1 | $600K | Sell |
14,704
-712
| -5% | -$29.1K | 0.19% | 71 |
|
|
2022
Q4 | $790K | Buy |
15,416
+648
| +4% | +$33.2K | 0.26% | 65 |
|
|
2022
Q3 | $646K | Sell |
14,768
-111
| -0.7% | -$4.86K | 0.23% | 72 |
|
|
2022
Q2 | $780K | Buy |
14,879
+266
| +2% | +$13.9K | 0.25% | 62 |
|
|
2022
Q1 | $757K | Buy |
14,613
+184
| +1% | +$9.53K | 0.22% | 62 |
|
|
2021
Q4 | $852K | Buy |
14,429
+529
| +4% | +$31.2K | 0.23% | 61 |
|
|
2021
Q3 | $598K | Buy |
13,900
+180
| +1% | +$7.74K | 0.17% | 83 |
|
|
2021
Q2 | $587K | Buy |
13,720
+891
| +7% | +$38.1K | 0.16% | 84 |
|
|
2021
Q1 | $464K | Buy |
12,829
+6,521
| +103% | +$236K | 0.15% | 89 |
|
|
2020
Q4 | $232K | Buy |
6,308
+284
| +5% | +$10.4K | 0.08% | 129 |
|
|
2020
Q3 | $210K | Buy |
+6,024
| New | +$210K | 0.09% | 122 |
|
|
2020
Q2 | – | Sell |
-6,526
| Closed | -$202K | – | 124 |
|
|
2020
Q1 | $202K | Sell |
6,526
-619
| -9% | -$19.2K | 0.11% | 107 |
|
|
2019
Q4 | $265K | Buy |
+7,145
| New | +$265K | 0.12% | 105 |
|